Portfolio company
PhageLab
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
PhageLab develops bacteriophage treatments to control bacterial pathogens in livestock and poultry production, reducing the industry's reliance on antibiotics.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Phagos
The company develops AI-powered bacteriophage treatments to combat antibiotic-resistant bacterial diseases, primarily for the animal farming and healthcare sectors.
EcoPhage
This company develops bacteriophage-based biopesticides to manage bacterial diseases in crops for the agricultural industry.
Animab
Animab develops oral monoclonal antibody products for livestock farmers to control gastrointestinal pathogens and improve animal health without using antibiotics.
Resilient Biotics
This company develops microbiome-derived live biotherapeutics to prevent and treat respiratory diseases in livestock and humans.
MetaBIX Biotech
The company develops an environmental biosurveillance platform that uses air sampling and artificial intelligence to predict disease outbreaks for animal production operators.
ArkVax
ArkVax develops low-cost recombinant glycoconjugate vaccines for the livestock industry to protect animals from bacterial diseases and combat antimicrobial resistance.
Aviwell
This company develops microbiota-based feed solutions using an AI discovery platform to improve livestock growth and health for the agri-food industry.
FeedVax
This company develops oral vaccines for the aquaculture industry to reduce fish stress and antibiotic use for producers.
